Genomic Features of Response to Combination Immunotherapy in Lung Cancer.

Details

Serval ID
serval:BIB_FD1D595C2E3A
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
Title
Genomic Features of Response to Combination Immunotherapy in Lung Cancer.
Journal
Cancer cell
Author(s)
Früh M., Peters S.
ISSN
1878-3686 (Electronic)
ISSN-L
1535-6108
Publication state
Published
Issued date
14/05/2018
Peer-reviewed
Oui
Volume
33
Number
5
Pages
791-793
Language
english
Notes
Publication types: Journal Article ; Comment
Publication Status: ppublish
Abstract
In this issue of Cancer Cell, Hellmann et al. describe in two clinical trials the importance of tumor mutational burden as an independent predictive marker for outcomes with combination nivolumab plus ipilimumab as first-line therapy in metastatic non-small-cell lung cancer and in relapsed small-cell lung cancer.
Keywords
Antibodies, Monoclonal, Carcinoma, Non-Small-Cell Lung, Genomics, Humans, Immunotherapy, Lung Neoplasms, Neoplasm Recurrence, Local
Pubmed
Web of science
Create date
17/05/2018 17:11
Last modification date
20/08/2019 16:28
Usage data